Cauble & Harre Wealth Management, Inc.

Position in NVS — Novartis AG

CIK 2064807 SAINT LOUIS, MO

Position in NVS

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$326,761

+$8,278 QoQ

Shares Held

2,085

0.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.76%

of 13F equity value

Holder Rank

#1,081

of 1,603 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Cauble & Harre Wealth Management, Inc. holds $1,547,412 across 4 Drug Manufacturers - General names. NVS ranks #4 (21.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	1,841	$467,558
2	MRK	Merck & Co., Inc.	3,262	$419,167
3	ABBV	AbbVie Inc.	1,327	$333,926
4	NVS	Novartis AG This page	2,085	$326,761

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$326,761	2,085	0.0%	Shares	Sole	2026-08-11
2026-03-31	$318,483	2,085	0.0%	Shares	Sole	2026-05-14
2025-12-31	$287,458	2,085	—	Shares	Sole	2026-02-05
No filing history on record for this holder in this stock.